MC

456.9

-1.13%↓

BNP

78.43

-0.09%↓

DB1.DE

254.8

-0.7%↓

NDA.FI

12.78

-0.16%↓

DIM

168.85

-1.14%↓

MC

456.9

-1.13%↓

BNP

78.43

-0.09%↓

DB1.DE

254.8

-0.7%↓

NDA.FI

12.78

-0.16%↓

DIM

168.85

-1.14%↓

MC

456.9

-1.13%↓

BNP

78.43

-0.09%↓

DB1.DE

254.8

-0.7%↓

NDA.FI

12.78

-0.16%↓

DIM

168.85

-1.14%↓

MC

456.9

-1.13%↓

BNP

78.43

-0.09%↓

DB1.DE

254.8

-0.7%↓

NDA.FI

12.78

-0.16%↓

DIM

168.85

-1.14%↓

MC

456.9

-1.13%↓

BNP

78.43

-0.09%↓

DB1.DE

254.8

-0.7%↓

NDA.FI

12.78

-0.16%↓

DIM

168.85

-1.14%↓

Search

Viscofan SA

Chiusa

SettoreFinanza

60.6 0.5

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

60.1

Massimo

61

Metriche Chiave

By Trading Economics

Entrata

-19M

31M

Vendite

1.5M

307M

P/E

Media del settore

17.23

25.916

EPS

0.685

Margine di Profitto

10.206

Dipendenti

5,480

EBITDA

-24M

65M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+20.23% upside

Dividendi

By Dow Jones

Utili prossimi

22 ott 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-42M

2.7B

Apertura precedente

60.1

Chiusura precedente

60.6

Notizie sul Sentiment di mercato

By Acuity

14%

86%

20 / 536 Classifica in Finance

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

Viscofan SA Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

4 ago 2025, 21:42 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4 ago 2025, 21:21 UTC

Utili
I principali Market Mover

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4 ago 2025, 20:45 UTC

Utili

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4 ago 2025, 19:15 UTC

I principali Market Mover

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4 ago 2025, 23:41 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

4 ago 2025, 23:41 UTC

Discorsi di Mercato

Nikkei May Rise on Fed Stimulus Hopes

4 ago 2025, 23:28 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

4 ago 2025, 23:28 UTC

Discorsi di Mercato

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4 ago 2025, 21:30 UTC

Utili

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 21:21 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4 ago 2025, 21:18 UTC

Utili

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 20:25 UTC

Discorsi di Mercato

India Hits Back Over Russian Oil Purchases -- Market Talk

4 ago 2025, 20:25 UTC

Utili

Transocean 2Q Loss $938M >RIG

4 ago 2025, 20:25 UTC

Utili

Transocean 2Q Loss/Shr $1.06 >RIG

4 ago 2025, 20:18 UTC

Utili

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4 ago 2025, 20:15 UTC

Utili

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4 ago 2025, 20:14 UTC

Utili

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4 ago 2025, 20:14 UTC

Utili

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4 ago 2025, 20:14 UTC

Utili

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4 ago 2025, 20:13 UTC

Utili

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4 ago 2025, 20:09 UTC

Utili

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4 ago 2025, 20:06 UTC

Utili

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4 ago 2025, 20:01 UTC

Utili

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4 ago 2025, 20:01 UTC

Utili

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4 ago 2025, 20:01 UTC

Utili

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4 ago 2025, 20:01 UTC

Utili

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4 ago 2025, 19:41 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Settle Lower -- Market Talk

4 ago 2025, 19:28 UTC

Discorsi di Mercato

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4 ago 2025, 19:07 UTC

Discorsi di Mercato

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4 ago 2025, 18:27 UTC

Discorsi di Mercato

Gold Climbs on Rate Cut Speculation -- Market Talk

Confronto tra pari

Modifica del prezzo

Viscofan SA Previsione

Obiettivo di Prezzo

By TipRanks

20.23% in crescita

Previsioni per 12 mesi

Media 72.5 EUR  20.23%

Alto 74 EUR

Basso 71 EUR

Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Viscofan SA - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

2 ratings

2

Acquista

0

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

63.6 / 64.4Supporto e resistenza

A breve termine

Strong Bearish Evidence

A termine intermedio

Strong Bullish Evidence

A lungo termine

Bullish Evidence

Sentiment

By Acuity

20 / 536 Classifica in Finanza

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Viscofan SA

Viscofan, S.A., together with its subsidiaries, manufactures, produces, and distributes casings. The company offers cellulose casings for cooked, smoked, unsmoked, and dry-cured sausages. It provides collagen casings for processed and pre-cooked fried sausages, and dry-cured snacks, as well as provides collagen film cover for meat products under Total Control Net brand. In addition, the company offers fibrous casings under TITANIUM LINE brand; and transfer plastic casings under VISPICE brand. Further, it provides plastic casings, nanopack plastic films, and shrink bag related products. The company was incorporated in 1975 and is based in Tajonar, Spain.